The National Italian American Foundation (NIAF) and the Sbarro Health Research Organization (SHRO) named Dr. Luana Colloca the recipient of the 2024 Giovan Giacomo Giordano-NIAF Lifetime Achievement Award for Ethics and Creativity in Medical Research.
In patients with human epidermal growth factor receptor 2 (HER2)-low breast cancer, the molecular classification of their case plays a pivotal role in the formulation of personalized treatment plans aimed at optimizing outcomes. Despite notable advancements in this field, significant challenges persist. Issues such as pre-analytical variability, interpretative ambiguity, and inconsistent threshold definitions hinder accurate diagnosis and subsequent treatment decisions. In this context, emerging liquid biopsy technologies present a promising solution.
Capsaicin, the compound in chili peppers which gives them their spicy taste, may become a source of new, natural drugs for the hard-to-treat Mesothelioma type of cancer.
The National Italian American Foundation (NIAF) presented its Leonardo da Vinci Award in Health and Science to National Institutes of Health (NIH) Director Monica M. Bertagnolli Saturday at the 49th annual NIAF gala in Washington, D.C.
On October 26, 2024, the National Italian-American Foundation (NIAF) will hold its 49th annual Gala at the Omni Shoreham Hotel in Washington D.C. As part of the weekend's prestigious events, the Sbarro Health Research Organization (SHRO) will host a scientific symposium focused on advancements in pain management.
Cancer patients frequently experience metabolic dysfunction leading to severe weight loss correlating with a poor prognosis. Causes for this dysfunction include malnutrition and cachexia, a systemic inflammation affecting brain mechanisms regulating satiety and hunger.
Temple University’s Sbarro Institute for Cancer Research and Molecular Medicine has benefited from the support of Pennsylvania State Sen. Ryan Aument since he took office in 2014.
The number of people living in a different place from their place of birth is increasing year by year. Although women have always been involved in migratory movements, today they are increasingly doing so independently. Women are migrating from the Global South to higher-income countries.
Canio Martinelli, M.D., MSc, GYN-OB resident at the University of Messina and visiting Ph.D. student in Translational Molecular Medicine and Surgery at the Sbarro Health Research Organization (SHRO), Temple University, has been honored with the 2024-2025 FDA-AACR Oncology Educational Fellowship.
The annual Taobuk International Literary Festival held in Taormina, Sicily has announced their 2024 Taobuk Awards, naming Professor Antonio Giordano, MD, PhD, President and Founder of the Sbarro Health Research Organization (SHRO), this year’s recipient of the Da Vinci Award.
Sbarro Health Research Organization (SHRO) Founder and Director, the Italian American Antonio Giordano, MD, PhD, climbs in the rankings of the top scientists in the United States and around the world. This recognition puts Giordano in the company of accomplished researchers in science and medicine globally. A source of pride for Italy but also for the States.
The pain of labor and childbirth may be reduced through the use of a Virtual Reality (VR) relaxation program timed with contractions.
May 22nd marked a significant milestone in the collaborative efforts to combat ovarian cancer as the "International Dialogue on Ovarian Cancer, from Bench to Bedside" congress was held, bridging the gap between primary research and clinical practice.
In the field of biomedical research and genomics, the advancement of bioinformatics technologies and tools is opening new frontiers in the understanding of diseases and their diagnosis and treatment.
Award recognizes Giordano for Italian Scientific Excellence in the world and the International Study on the correlation between health and pollution in the Land of Fire in Campania
Italians residing abroad and registered with the EU health card service are guaranteed the maintenance of medical assistance and health exemptions when they return to Italy.
Malignant mesothelioma is a very aggressive cancer with a very poor survival and limited treatment options. Thus, a deeper knowledge of the mechanisms modulating mesothelioma initiation and progression is critical for novel therapeutic strategies.
With funding from the Commonwealth of Pennsylvania and the Sbarro Health Research Organization (SHRO), the latest incubator and technology transfer institute opens at Temple University.
Researchers describe a newly-observed role for the protein Cyclin Dependent Kinase 9 (CDK9) in regulating DNA repair during cellular division, where errors can become the origin of cancerous tumor growth.
Cristiana Della’Anna, the actress who portrays Mother Cabrini in the upcoming biopic, Cabrini, visits with Sbarro Health Research Organization Founder and President Antonio Giordano
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right